In a move that will see the expansion of its range of igaming products,
online casino and white label solutions provider
Aspire Global recently penned a deal with SBTech that will see the 2017 SBC Awards winner of the "Sportsbook Supplier of the Year" initially go live with its flagship Karamba brand.
The Malta-based group is now live with its UK-facing online casino
Karamba, and as complement to its existing offering of live casino, slots, table games, scratch and instant games, will now offer SBTech’s acclaimed
sportsbook.
Chief Executive Officer for Aspire Global Tsachi Maimon, commented: “We are thrilled to add this new and engaging vertical to our solution, and are confident that the collaboration with SBTech will be a successful venture for both parties. The decision to choose SBTech as our sportsbook provider was based on its ability to adjust its product offering to our unique solution and the needs of our operators. This partnership will enhance the diversity of our offering to our partners and will continue the positive trend of growth experienced over the past few years,” according to the
press release.
Also commenting on the collaboration, Chief Executive Officer for SBTech Richard Carter, added: “This launch confirms SBTech’s position as the leading supplier of sports betting solutions for the sector’s top operators. We’re anticipating significant growth for all of Aspire Global’s partners, thanks to our expertise in deploying flexible trading and content solutions, with unique focus on cross-selling from casino to sports.”
Up to now, Aspire Global’s focus has been on offering a full online casino solution to white label clients and operators. The addition of the market-leading sportsbook from SBTech will allow it to increase revenues for its operators and widen its product offering.
Just recently,
SBTech entered into a strategic partnership with GameAccount Network in anticipation of a positive outcome to the Christie v NCAA case currently being considered by the United States Supreme Court.
No comments:
Post a Comment